1. Danger, R, Thervet, E, Grisoni, M-L, Soulillou, J P, Brouard, S. . PARVG gene polymorphism and operational renal allograft tolerance. In Transplantation proceedings, 44, 2845-8. doi:10.1016/j.transproceed.2012.09.034. https://pubmed.ncbi.nlm.nih.gov/23146538/
2. Wang, Fei, Bi, Juan, Yi, Chunxia, Zhang, Yu, Yue, Qingfang. 2022. Relationship between Prognosis, Immune Infiltration Level, and Differential Expression of PARVG Gene in Uterine Corpus Endometrial Carcinoma. In Contrast media & molecular imaging, 2022, 7376588. doi:10.1155/2022/7376588. https://pubmed.ncbi.nlm.nih.gov/35655721/
3. Castellví-Bel, Sergi, Castells, Antoni, Johnstone, Cameron N, Rustgi, Anil K, Piqué, Josep M. . Evaluation of PARVG located on 22q13 as a candidate tumor suppressor gene for colorectal and breast cancer. In Cancer genetics and cytogenetics, 144, 80-2. doi:. https://pubmed.ncbi.nlm.nih.gov/12810262/
4. Alonso, M Eva, Bello, M Josefa, de Campos, Jose M, Sarasa, Jose L, Rey, Juan A. . No evidence of INI1hSNF5 (SMARCB1) and PARVG point mutations in oligodendroglial neoplasms. In Cancer genetics and cytogenetics, 160, 169-73. doi:. https://pubmed.ncbi.nlm.nih.gov/15993274/